TRDA
Entrada TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
TRDA vs peer average
20/100
TRDA vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AKBA is the first available peer comparator.
Small-cap biotech comp for event-driven volatility and financing sensitivity, but only a loose operating peer because the disease area and modality differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TRDA
Entrada Therapeutics
AKBA
Akebia Therapeutics
Grade
F
D
Momentum
1
16
Value
58
66
Sentiment
59
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AKBA
TRDA / AKBA
Grade Position
Below peers
TRDA vs. peer average (F vs. C)
20/100
Momentum
1
AKBAValue
58
AKBASentiment
59
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TRDA
AKBA is the first peer returned for this comparison set.